Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1983 1
1988 1
1992 1
1994 1
1995 1
1998 1
2000 2
2003 2
2004 3
2005 4
2006 5
2007 4
2008 5
2009 2
2010 2
2011 6
2012 7
2013 5
2014 7
2015 9
2016 8
2017 6
2018 3
2019 10
2020 9
2021 10
2022 6
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT?
Campo F, Iocca O, De Virgilio A, Mazzola F, Mercante G, Pichi B, Holsinger FC, Di Maio P, Ramella S, Pellini R. Campo F, et al. Radiother Oncol. 2023 Jun;183:109547. doi: 10.1016/j.radonc.2023.109547. Epub 2023 Feb 20. Radiother Oncol. 2023. PMID: 36813176 Review.
BACKGROUND AND PURPOSE: To answer an important question regarding the long-term morbidity of two oncological equivalent treatment for oropharyngeal squamous cell carcinoma (OPSCC), namely a comparison of swallowing function results between patients treated with tran …
BACKGROUND AND PURPOSE: To answer an important question regarding the long-term morbidity of two oncological equivalent treatment for oro …
Treatment options for oropharyngeal carcinoma - An umbrella review.
Plutecki D, Szczepanek E, Szczepanek M, Nasser A, Hajdyła P, Wrona A. Plutecki D, et al. Folia Med Cracov. 2023 Oct 30;63(3):103-124. doi: 10.24425/fmc.2023.147217. Folia Med Cracov. 2023. PMID: 38310532 Free article. Review.
INTRODUCTION: Our umbrella review aimed to summarize and revisit the evidence from all of the meta-analyses and systematic reviews regarding the treatments of oropharyngeal squamous cell carcinoma (OPSCC). MATERIALS AND METHODS: Major medical databases such as PubMe …
INTRODUCTION: Our umbrella review aimed to summarize and revisit the evidence from all of the meta-analyses and systematic reviews regarding …
Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis.
Petrelli F, Luciani A, Ghidini A, Cherri S, Gamba P, Maddalo M, Bossi P, Zaniboni A. Petrelli F, et al. Head Neck. 2022 May;44(5):1255-1266. doi: 10.1002/hed.27019. Epub 2022 Mar 3. Head Neck. 2022. PMID: 35238114 Review.
Human Papillomavirus (HPV) related oropharyngeal carcinoma (OPC) carries a better prognosis compared with HPV-counterparts, thereby pushing the adoption of de-intensification treatment approaches as new strategies to preserve superior oncologic outcomes while minimi …
Human Papillomavirus (HPV) related oropharyngeal carcinoma (OPC) carries a better prognosis compared with HPV-counterparts, th …
Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma.
De Virgilio A, Costantino A, Mercante G, Petruzzi G, Sebastiani D, Franzese C, Scorsetti M, Pellini R, Malvezzi L, Spriano G. De Virgilio A, et al. Curr Oncol Rep. 2020 Jul 9;22(9):91. doi: 10.1007/s11912-020-00948-1. Curr Oncol Rep. 2020. PMID: 32643045 Review.
PURPOSE OF REVIEW: The treatment of patients with squamous cell carcinoma of the oropharynx (OPSCC) remains controversial. HPV positivity is widely accepted as a favorable prognostic factor, and HPV+ OPSCC is considered a distinct pathological entity with dedicated NCCN gu …
PURPOSE OF REVIEW: The treatment of patients with squamous cell carcinoma of the oropharynx (OPSCC) remains controversial. HPV positi …
Detection of Recurrence After Primary Treatment for Oropharyngeal Carcinoma.
Landström F, Reizenstein J, Kristiansson S. Landström F, et al. Anticancer Res. 2022 Nov;42(11):5597-5600. doi: 10.21873/anticanres.16067. Anticancer Res. 2022. PMID: 36288847
BACKGROUND/AIM: Post-treatment surveillance of patients with squamous cell oropharyngeal carcinoma (SCOPC) consists of routine follow-up visits for 5 years. ...
BACKGROUND/AIM: Post-treatment surveillance of patients with squamous cell oropharyngeal carcinoma (SCOPC) consists of routine …
HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
Wang MB, Liu IY, Gornbein JA, Nguyen CT. Wang MB, et al. Otolaryngol Head Neck Surg. 2015 Nov;153(5):758-69. doi: 10.1177/0194599815592157. Epub 2015 Jun 29. Otolaryngol Head Neck Surg. 2015. PMID: 26124261 Review.
OBJECTIVE: Human papillomavirus-positive (HPV+) head and neck squamous cell carcinoma is increasing in incidence and appears to exhibit improved response to treatment and better survival than that of HPV- head and neck squamous cell carcinoma. The purpose of this sy …
OBJECTIVE: Human papillomavirus-positive (HPV+) head and neck squamous cell carcinoma is increasing in incidence and appears to exhib …
Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.
Chinn SB, Myers JN. Chinn SB, et al. J Clin Oncol. 2015 Oct 10;33(29):3269-76. doi: 10.1200/JCO.2015.61.2929. Epub 2015 Sep 8. J Clin Oncol. 2015. PMID: 26351335 Free PMC article. Review.
Oral cavity carcinoma (OCC) remains a major cause of morbidity and mortality in patients with head and neck cancer. ...Likewise, although the association of human papillomavirus is well established in oropharyngeal carcinoma, it has not been proven in the pat …
Oral cavity carcinoma (OCC) remains a major cause of morbidity and mortality in patients with head and neck cancer. ...Likewise, alth …
The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N, Faraji F, Kang H, Fakhry C. Fung N, et al. Cancer Metastasis Rev. 2017 Sep;36(3):449-461. doi: 10.1007/s10555-017-9686-9. Cancer Metastasis Rev. 2017. PMID: 28812214 Review.
Human papillomavirus positive oropharyngeal cancer (HPV-positive OPC) is a distinct subtype of head and neck carcinoma (HNC) distinguished from HPV-negative HNC by its risk factor profile, clinical behavior, and molecular biology. ...Recognition of the survival bene …
Human papillomavirus positive oropharyngeal cancer (HPV-positive OPC) is a distinct subtype of head and neck carcinoma (HNC) d …
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives.
Mirghani H, Amen F, Blanchard P, Moreau F, Guigay J, Hartl DM, Lacau St Guily J. Mirghani H, et al. Int J Cancer. 2015 Apr 1;136(7):1494-503. doi: 10.1002/ijc.28847. Epub 2014 Apr 4. Int J Cancer. 2015. PMID: 24622970 Free article. Review.
Due to the generally poor prognosis of head and neck squamous cell carcinoma (HNSCC), treatment has been intensified, these last decades, leading to an increase of serious side effects. High-risk human papillomavirus (HR-HPV) infection has been recently etiologically linke …
Due to the generally poor prognosis of head and neck squamous cell carcinoma (HNSCC), treatment has been intensified, these last deca …
Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?
Samuels SE, Eisbruch A, Beitler JJ, Corry J, Bradford CR, Saba NF, van den Brekel MW, Smee R, Strojan P, Suárez C, Mendenhall WM, Takes RP, Rodrigo JP, Haigentz M Jr, Rapidis AD, Rinaldo A, Ferlito A. Samuels SE, et al. Eur Arch Otorhinolaryngol. 2016 Oct;273(10):2877-94. doi: 10.1007/s00405-015-3771-x. Epub 2015 Oct 13. Eur Arch Otorhinolaryngol. 2016. PMID: 26463714 Review.
HPV-related (HPV+) oropharyngeal cancer (OPC) has a better prognosis compared to HPV unrelated (HPV-) OPC. ...
HPV-related (HPV+) oropharyngeal cancer (OPC) has a better prognosis compared to HPV unrelated (HPV-) OPC. ...
109 results